Foyston, Gordon & Payne Inc

Holdings History for ABBOTT LABORATORIES - Common Stock (ABT)

Symbol: ABT on NYSE
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.33%	0%	$1,528,538	12,200	0		$125.29	Q4 2025
30 Sep 2025	0.36%	0%	$1,634,068	12,200	0		$133.94	Q3 2025
30 Jun 2025	0.38%	0%	$1,659,322	12,200	0		$136.01	Q2 2025
31 Mar 2025	0.4%	0%	$1,618,330	12,200	0		$132.65	Q1 2025
31 Dec 2024	0.37%	0%	$1,379,942	12,200	0		$113.11	Q4 2024
30 Sep 2024	0.35%	0%	$1,390,922	12,200	0		$114.01	Q3 2024
30 Jun 2024	0.31%	0%	$1,267,702	12,200	0		$103.91	Q2 2024
31 Mar 2024	0.33%	0%	$1,386,652	12,200	0		$113.66	Q1 2024
31 Dec 2023	0.34%	0%	$1,342,854	12,200	0		$110.07	Q4 2023
30 Sep 2023	0.32%	0%	$1,181,570	12,200	0		$96.85	Q3 2023
30 Jun 2023	0.35%	0%	$1,330,044	12,200	0		$109.02	Q2 2023
31 Mar 2023	0.33%	0%	$1,235,372	12,200	0		$101.26	Q1 2023
31 Dec 2022	0.37%	0%	$1,339,438	12,200	0		$109.79	Q4 2022
30 Sep 2022	0.32%	0%	$1,180,000	12,200	0		$96.72	Q3 2022
30 Jun 2022	0.68%	0%	$1,326,000	12,200	0		$108.69	Q2 2022
31 Mar 2022	0.35%	0%	$1,444,000	12,200	0		$118.36	Q1 2022
31 Dec 2021	0.4%	0%	$1,717,000	12,200	0		$140.74	Q4 2021
30 Sep 2021	0.36%	0%	$1,441,000	12,200	0		$118.11	Q3 2021
30 Jun 2021	0.34%	-0.02%	$1,414,000	12,200	-600	-4.7%	$115.90	Q2 2021
31 Mar 2021	0.36%	0%	$1,534,000	12,800	0		$119.84	Q1 2021
31 Dec 2020	0.34%	0%	$1,401,000	12,800	0		$109.45	Q4 2020
30 Sep 2020	0.36%	0%	$1,393,000	12,800	0		$108.83	Q3 2020
30 Jun 2020	0.29%	0%	$1,170,000	12,800	0		$91.41	Q2 2020
31 Mar 2020	0.26%	0%	$1,010,000	12,800	0		$78.91	Q1 2020
31 Dec 2019	0.21%	0%	$1,112,000	12,800	0		$86.88	Q4 2019
30 Sep 2019	0.21%	0%	$1,071,000	12,800	0		$83.67	Q3 2019
30 Jun 2019	0.2%	0%	$1,076,000	12,800	0		$84.06	Q2 2019
31 Mar 2019	0.2%	0%	$1,023,000	12,800	0		$79.92	Q1 2019
31 Dec 2018	0.19%	0%	$926,000	12,800	0		$72.34	Q4 2018
30 Sep 2018	0.16%	-0%	$939,000	12,800	-43	-0.33%	$73.36	Q3 2018
30 Jun 2018	0.14%	0%	$783,000	12,843	0		$60.97	Q2 2018
31 Mar 2018	0.15%	0%	$770,000	12,843	0		$59.95	Q1 2018
31 Dec 2017	0.14%	0%	$733,000	12,843	0		$57.07	Q4 2017
30 Sep 2017	0.12%	0%	$685,000	12,843	0		$53.34	Q3 2017
30 Jun 2017	0.13%	-0.01%	$624,000	12,843	-560	-4.2%	$48.59	Q2 2017
31 Mar 2017	0.13%	-0%	$595,000	13,403	-57	-0.42%	$44.39	Q1 2017
31 Dec 2016	0.12%	0%	$517,000	13,460	0		$38.41	Q4 2016
30 Sep 2016	0.11%	0%	$569,000	13,460	0		$42.27	Q3 2016
30 Jun 2016	0.1%	-0%	$529,000	13,460	-415	-3%	$39.30	Q2 2016
31 Mar 2016	0.11%	+0%	$580,000	13,875	+340	+2.5%	$41.80	Q1 2016
31 Dec 2015	0.11%	+0.01%	$608,000	13,535	+600	+4.6%	$44.92	Q4 2015
30 Sep 2015	0.22%	+0%	$520,000	12,935	+100	+0.78%	$40.20	Q3 2015
30 Jun 2015	0.09%	+0%	$630,000	12,835	+560	+4.6%	$49.08	Q2 2015
31 Mar 2015	0.08%	+0%	$569,000	12,275	+75	+0.61%	$46.35	Q1 2015
31 Dec 2014	0.08%	0%	$549,000	12,200	0		$45.00	Q4 2014
30 Sep 2014	0.07%	0%	$507,000	12,200	0		$41.56	Q3 2014
30 Jun 2014	0.06%	-0%	$499,000	12,200	-186	-1.5%	$40.90	Q2 2014
31 Mar 2014	0.06%	-0%	$477,000	12,386	-184	-1.5%	$38.51	Q1 2014
31 Dec 2013	0.06%	0%	$482,000	12,570	0		$38.35	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.